TV 목록 보기
증권
지난 주요뉴스 한국경제TV에서 선정한 지난 주요뉴스 뉴스썸 한국경제TV 웹사이트에서 접속자들이 많이 본 뉴스 한국경제TV 기사만 onoff
[PRNewswire] NuZee (d/b/a Coffee Blenders(R)) Closes Underwritten Public 2020-06-24 10:12:40
[PRNewswire] NuZee (d/b/a Coffee Blenders(R)) Closes Underwritten Public Offering Of Common Stock And Announces Uplisting To NASDAQ (PLANO, Texas, June 23, 2020 PRNewswire=연합뉴스) NuZee, Inc. (NASDAQ: NUZE) ("NuZee"), a single-serve pour-over coffee producer and co-packer, announced today the...
[NH디지털혁신캠퍼스] 이훈구 위티 대표 “AI+공간빅데이터를 기반으로 3시간 발품을 단 1분만에” 2020-06-23 11:02:00
텍사스 Texas A&M 대학에서 석사학위를 취득한 후 2014년, 불과 30대에 GIS(지리정보시스템)를 전문으로 하는 국내의 한 건설회사에서 이사격인 연구소장으로 일했다. “일을 하면 할수록, 공간을 더 깊이 있게 공부해보고 싶었고, 박사 과정으로 서울대 공간정보연구실에서 GIS와 LBS(위치기반서비스)를 연구했어요....
[PRNewswire] Investigational, Once-weekly Insulin Icodec Showed Comparable 2020-06-15 09:33:27
trial investigator and clinical professor of medicine, University of Texas Southwestern Medical Center, US. "I'm truly excited about the potential of such innovative treatments which could reduce the number of basal insulin injections for my patients with diabetes." Hypoglycaemia, also known as...
[PRNewswire] 머크와 베일러의과대학, 코비드-19 백신 제조 플랫폼 위해 지속 협력 2020-05-28 09:19:32
College of Medicine and the Texas Children's Hospital Center for Vaccine Development received funding from NAID for their earlier work in developing the CoV RBD219-N1 vaccine candidate and recently to initiate development of the second Covid-19 vaccine candidate. In addition, Baylor and Texas...
[PRNewswire] 파이브로제네시스, 섬유아세포 세포치료 활용해 코비드-19 극복 2020-05-22 10:31:13
to regenerating damage the COVID-19 virus causes to lungs. This is the best result we could have hoped for." About FibroGenesis Based in Houston, Texas, FibroGenesis, is a regenerative medicine company developing an innovative solution for chronic disease treatment using human dermal fibroblasts....
[PRNewswire] 이노비오, COVID-19 DNA 백신 INO-4800의 전임상 실험 결과 발표 2020-05-20 21:06:39
of Texas, Public Health England, Fudan University, and Advaccine. Dr. Kate Broderick, INOVIO's Senior Vice President of R&D and the Team Lead for COVID-19 vaccine development, said, "These positive preclinical results from our COVID-19 DNA vaccine (INO-4800) not only highlight the potency of our...
[PRNewswire] 뉴지(d/b/a 커피블렌더스(R)), 동사 보통주의 상장 작업 시작 발표 2020-05-18 16:36:08
NuZee Logo 출처: 뉴지(NuZee, Inc.) NuZee (d/b/a Coffee Blenders(R)) Announces The Commencement Of Proposed Public Offering Of Common Stock PLANO, Texas, May 18, 2020 /PRNewswire/ -- NuZee, Inc. (OTCQB: NUZE) ("NuZee"), a single-serve pour-over coffee producer and co-packer, announced today that it...
[PRNewswire] 리지우드인프라스트럭처, 마이클 알브레히트와 샘 리스너의 승진 발표 2020-05-07 10:42:52
San Antonio, Texas with approximately 20 percent of its fresh water under long-term contract, and SiEnergy, a regulated natural gas utility serving approximately 25,000 customers. For more information, please visit www.ridgewoodinfrastructure.com. Contact info: For More Information: Ridgewood...
[PRNewswire] INOVIO and GeneOne Life Science Report Positive Phase 1/2a 2020-04-29 09:45:30
Texas. INOVIO has partnered with Beijing Advaccine and the International Vaccine Institute to advance clinical trials of INO-4800 in China and South Korea, respectively. INOVIO is also assessing preclinical efficacy of INO-4800 in several animal challenge models with Public Health England (PHE) and...
[PRNewswire] 이노비오, 코비드-19 DNA백신 위한 미국 임상 1상 시험 등록 완료 2020-04-29 09:27:17
of Texas)을 포함한다. 이노비오는 중국과 한국에서 각각 INO-4800의 임상시험을 진행하기 위해 베이징 애드백신(Beijing Advaccine)과 국제 백신 연구소(International Vaccine Institute)와 협력하고 있다. 또한, 호주의 CSIRO(Commonwealth Scientific and Industrial Research Organization)와 PHE(Public Health...
TV 목록 보기
증권
